FIELD: medicine, pharmaceutical industry.
SUBSTANCE: invention represents a drug of the following composition, wt.-%: chondroitin sulfate, 1.0-10.0; sodium diclofenac, 1.0-10.0; dimethylsulfoxide, 5.0-25.0, and ointment base, the balance. Ointment base represents pentol, stearic acid, vaseline, lanolin and water, polymeric-base gel, or polyethylene oxides. Proposed drug possesses the combined effect.
EFFECT: improved and valuable medicinal properties of agent.
2 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
MEDICINAL COMPOSITION FOR TREATING JOINT DISEASES (VERSIONS) | 2009 |
|
RU2408380C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271812C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271811C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
COMBINED ACTIVE COMPOSITION FOR TREATING LOCOMOTOR DISEASES | 2015 |
|
RU2582974C1 |
EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
Authors
Dates
2008-04-20—Published
2006-10-03—Filed